766 related articles for article (PubMed ID: 15473886)
1. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
3. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
[TBL] [Abstract][Full Text] [Related]
4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
5. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
Serin O; Konukoglu D; Firtina S; Mavis O
Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
[TBL] [Abstract][Full Text] [Related]
6. Exogenous subclinical hyperthyroidism impairs endothelial function in nodular goiter patients.
Yavuz DG; Yazici D; Toprak A; Deyneli O; Aydin H; Yüksel M; Akalin S
Thyroid; 2008 Apr; 18(4):395-400. PubMed ID: 18399765
[TBL] [Abstract][Full Text] [Related]
7. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
8. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
9. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
10. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
12. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC
Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045
[TBL] [Abstract][Full Text] [Related]
13. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
15. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
[TBL] [Abstract][Full Text] [Related]
16. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism.
Kebapcilar L; Akinci B; Bayraktar F; Comlekci A; Solak A; Demir T; Yener S; Küme T; Yesil S
Med Princ Pract; 2007; 16(6):432-6. PubMed ID: 17917442
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and management of multinodular goiter.
Hurley DL; Gharib H
Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
[TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease.
Verit FF; Erel O; Celik N
Hum Reprod; 2008 Jan; 23(1):100-4. PubMed ID: 18000171
[TBL] [Abstract][Full Text] [Related]
20. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
